Amid Hype Over Narcan First Generic, A Plea For A Labeling Change

Naloxone distribution programs ask that the cheaper generic injectable formulation have the same community-use language in its label as the nasal spray and auto-injector so they can maximize their distribution efforts.

Opioids - 3D Image

The US FDA's approval of a generic version of Adapt Pharma Ltd.'s Narcan (naloxone hydrochloride) nasal spray may represent an advance in the opioid overdose treatment's availability, but public health advocates argue a simple labeling change may prove more effective.

Many community health programs, who distribute naloxone to opioid users, often on small budgets, say that the label for generic...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership